Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study

Regularly scheduled intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are essential to maintaining and/or improving many ocular conditions including: neovascular age-related macular degeneration (nAMD), diabetic retinopathy, and retinal vein occlusions with macular edema (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Naravane, Ameay V., Mundae, Rusdeep, Zhou, Yujia, Santilli, Christopher, van Kuijk, Frederik J. G. M., Nazari, Hossein, Yamanuha, Justin, Emerson, Geoffrey G., Koozekanani, Dara D., Montezuma, Sandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888661/
https://www.ncbi.nlm.nih.gov/pubmed/33596257
http://dx.doi.org/10.1371/journal.pone.0247161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888661/
https://www.ncbi.nlm.nih.gov/pubmed/33596257
http://dx.doi.org/10.1371/journal.pone.0247161

Ejemplares similares